Related Experiment Video
Updated: Jun 22, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Can modular analysis identify disease-associated candidate genes for therapeutics?
1Department of Medicine, Center for Molecular Medicine, Karolinska University Hospital, 171 76 Solna, Stockholm, Sweden. jesper.tegner@ki.se
Complex diseases like allergy alter gene expression. A new modular analysis strategy effectively studied this complexity, revealing key allergy-associated genes with therapeutic potential.
Area of Science:
- Systems biology
- Immunology
- Genetics
Background:
- Complex diseases, including allergies, involve widespread changes in gene expression across multiple cell types and tissues.
- Understanding these intricate molecular alterations is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the complex gene expression changes associated with allergies.
- To identify a core set of allergy-associated genes with potential therapeutic applications.
Main Methods:
- Development and application of an integrated experimental and computational modular analysis strategy.
- Analysis of gene expression patterns in relevant cell types and tissues.
Main Results:
- The modular analysis effectively captured the complexity of allergy-associated gene expression changes.
- Identification of a core group of genes significantly linked to allergic responses.
- These core genes represent potential targets for novel allergy therapies.
Conclusions:
- Integrated experimental and computational modular analysis is a powerful approach for studying complex diseases like allergy.
- The identified core allergy-associated genes warrant further investigation for therapeutic development.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Drug Discovery: Overview
